Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey

被引:27
|
作者
Xie, Shitong [1 ,2 ]
Wang, Dingyao [2 ,3 ]
Wu, Jing [2 ,3 ]
Liu, Chunyu [4 ]
Jiang, Wenchen [5 ]
机构
[1] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[2] Tianjin Univ, Sch Pharmaceut Sci & Technol, Room 209,24th Bldg,92th Weijin Rd, Tianjin 300072, Peoples R China
[3] Tianjin Univ, Ctr Social Sci Survey & Data, Tianjin, Peoples R China
[4] Tianjin Hlth Informat Res Ctr, Tianjin Hlth Dev Res Ctr, Tianjin, Peoples R China
[5] Tianjin Hosp Integrated Tradit Chinese & Western, 6th Changjiang Rd, Tianjin 300100, Peoples R China
基金
中国国家自然科学基金;
关键词
Health-related quality of life; SF-6Dv2; EQ-5D-5L; Measurement properties; Population health survey; QUALITY-OF-LIFE; PREFERENCE-BASED MEASURE; EUROQOL; SCORES; PERFORMANCE; VALIDATION; AGREEMENT; INDEX; STATE; SF-12;
D O I
10.1186/s12955-022-02003-y
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background SF-6Dv2, the latest version of SF-6D, has been developed recently, and its measurement properties remain to be evaluated and compared with the EQ-5D-5L. The aim of this study was to assess and compare the measurement properties of the SF-6Dv2 and the EQ-5D-5L in a large-sample health survey among the Chinese population. Methods Data were obtained from the 2020 Health Service Survey in Tianjin, China. Respondents were randomly selected and invited to complete both the EQ-5D-5L and SF-6Dv2 through face-to-face interviews or self-administration. Health utility values were calculated by the Chinese value sets for the two measures. Ceiling and floor effects were firstly evaluated. Convergent validity and discriminate validity were examined using Spearman's rank correlation and effect sizes, respectively. The agreement was assessed using intraclass correlation coefficients (ICC). Sensitivity was compared using relative efficiency and receiver operating characteristic. Results Among 19,177 respondents (49.3% male, mean age 55.2 years, ranged 18-102 years) included in this study, the mean utility was 0.939 (0.168) for EQ-5D-5L and 0.872 (0.184) for SF-6Dv2. A higher ceiling effect was observed in EQ-5D-5L than in SF-6Dv2 (72.8% vs. 36.1%). The Spearman's rank correlation (range: 0.30-0.69) indicated an acceptable convergent validity between the dimensions of EQ-5D-5L and SF-6Dv2. The SF-6Dv2 showed slightly better discriminative capacities than the EQ-5D-5L (ES: 0.126-2.675 vs. 0.061-2.256). The ICC between the EQ-5D-5L and SF-6Dv2 utility values of the total sample was 0.780 (p < 0.05). The SF-6Dv2 had 29.0-179.2% higher efficiency than the EQ-5D-5L at distinguishing between respondents with different external health indicators, while the EQ-5D-5L was found to be 8.2% more efficient at detecting differences in self-reported health status than the SF-6Dv2. Conclusions Both the SF-6Dv2 and EQ-5D-5L have been demonstrated to be comparably valid and sensitive when used in Chinese population health surveys. The two measures may not be interchangeable given the moderate ICC and the systematic difference in utility values between the SF-6Dv2 and EQ-5D-5L. Further research is warranted to compare the test-retest reliability and responsiveness.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] A head-to-head comparison of the measurement properties of EQ-5D-3L and EQ-5D-5L in Chinese family caregivers of cancer patients
    Zhang, Huan
    Liu, Bo
    Gu, Wen
    Cao, Yiyin
    Xu, Juan
    Tan, Rachel Lee-Yin
    Chang, Enxue
    Zheng, Wanji
    Li, Haofei
    Zhou, Lan
    Jia, Yanni
    Yang, Hongbin
    Guo, Sheng
    Huang, Weidong
    Luo, Nan
    SUPPORTIVE CARE IN CANCER, 2024, 32 (01)
  • [42] Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis
    Thaweethamcharoen, Tanita
    Noparatayaporn, Prapaporn
    Sritippayawan, Suchai
    Aiyasanon, Nipa
    VALUE IN HEALTH REGIONAL ISSUES, 2019, 18 : 59 - 64
  • [43] Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
    Shiroiwa, Takeru
    Fukuda, Takashi
    Ikeda, Shunya
    Igarashi, Ataru
    Noto, Shinichi
    Saito, Shinya
    Shimozuma, Kojiro
    QUALITY OF LIFE RESEARCH, 2016, 25 (03) : 707 - 719
  • [44] COMPARISON BETWEEN THE EQ-5D-5L AND THE EQ-5D-3L FOR GENERAL POPULATION IN CHINA
    Zhou, T.
    Guan, H. J.
    Ma, A.
    Liu, G. G.
    VALUE IN HEALTH, 2016, 19 (07) : A829 - A829
  • [45] JAPANESE POPULATION NORMS FOR PREFERENCE-BASED MEASURES: EQ-5D-3L, EQ-5D-5L, AND SF-6D
    Shiroiwa, T.
    Fukuda, T.
    Ikeda, S.
    Igarashi, A.
    Noto, S.
    Saito, S.
    Shimozuma, K.
    VALUE IN HEALTH, 2015, 18 (07) : A738 - A738
  • [46] Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia
    Xu, Richard Huan
    Dong, Dong
    Luo, Nan
    Wong, Eliza Lai-Yi
    Wu, Yushan
    Yu, Siyue
    Yang, Renchi
    Liu, Junshuai
    Yuan, Huiqin
    Zhang, Shuyang
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2021, 22 (04): : 547 - 557
  • [47] Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
    Takeru Shiroiwa
    Takashi Fukuda
    Shunya Ikeda
    Ataru Igarashi
    Shinichi Noto
    Shinya Saito
    Kojiro Shimozuma
    Quality of Life Research, 2016, 25 : 707 - 719
  • [48] EQ-5D-5L Population Norms for China Derived From a National Health Survey
    Li, Dan-Lin
    Wang, Zi-Tong
    Nie, Xin-Yi
    Luo, Nan
    Wu, Yi-Bo
    Pan, Chen-Wei
    Wang, Pei
    VALUE IN HEALTH, 2024, 27 (08) : 1108 - 1120
  • [49] EQ-5D-5L Population Norms and Health Inequality in Colombia
    Bailey, Henry H.
    Janssen, Mathieu F.
    Varela, Rodrigo O.
    Moreno, Jhon A.
    VALUE IN HEALTH REGIONAL ISSUES, 2021, 26 : 24 - 32
  • [50] Health utility measurement for people living with HIV/AIDS under combined antiretroviral therapy: A comparison of EQ-5D-5L and SF-6D
    Wang, Xiaowen
    Luo, Hongbing
    Yao, Enlong
    Tang, Renhai
    Dong, Wenbing
    Liu, Fuyong
    Liang, Jun
    Xiao, Minyang
    Zhang, Zuyang
    Niu, Jin
    Song, Lijun
    Fu, Liru
    Li, Xuehua
    Qian, Shicong
    Guo, Qing
    Song, Zhizhong
    MEDICINE, 2022, 101 (45) : E31666